Position in LLY
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$4,886,478
+$2,667,993 QoQ
Shares Held
4,074
+68.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.88%
of 13F equity value
Holder Rank
#1,734
of 4,605 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 68%
Shared 0%
None 32%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TEALWOOD ASSET MANAGEMENT INC holds $22,831,272 across 7 Drug Manufacturers - General names. LLY ranks #1 (21.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
4,074 | $4,886,478 | |
| 2 | ABBV |
AbbVie Inc.
|
14,888 | $3,746,416 | |
| 3 | NVS |
Novartis AG
|
22,271 | $3,490,311 | |
| 4 | AZN |
Astrazeneca PLC
|
17,577 | $3,332,950 | |
| 5 | JNJ |
Johnson & Johnson
|
12,345 | $3,135,259 | |
| 6 | MRK |
Merck & Co., Inc.
|
19,133 | $2,458,590 | |
| 7 | AMGN |
Amgen Inc
|
4,919 | $1,781,268 |
All Filings in LLY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,886,478 | 4,074 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $2,218,485 | 2,412 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $2,601,800 | 2,421 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $1,917,419 | 2,513 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $1,393,799 | 1,788 | Shares | Sole | 2025-07-17 | |
| No filing history on record for this holder in this stock. | ||||||